Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment
Clinical trial NCT07477119 · RECRUITING
Trial details
- NCT number
- NCT07477119
- Sponsor
- Marco Schiuma
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-10-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.